Abstract
Despite incredible advancement made in recent years, treatment of cancer still remains the most challenging task for the mankind. The new small molecule therapeutic drugs are more specific, exhibit better therapeutic efficacy and mostly contain scaffolds of β-lactam, sulfonamide, quinoline, quinazoline, quinoxaline, purine, pyrimidine, resorcinol, pyrazole/isoxazole, benzamide etc. The structure-activity relationships of different pharmacophores that have been reported to potently inhibit cell growth of human tumour cell lines are constantly being investigated. Development of products of natural origin can also prove effective without submitting to harmful radiation and chemotherapy treatments. Under these circumstances, the practicing organic chemists are greatly facing the challenge of designing new and leading anti-cancer drugs based on natural products and scaffolds of potent pharmacaophores. The review intends to cover new approach of anti-cancer drug design using natural and synthetic pharmacophores. The plausible synthetic routes to major drugs for oncology that were approved recently by Food and Drug Administration (FDA) are also discussed.
Keywords: Anti-cancer drug, phamacophoric scaffold, oncology, synthesis, natural & herbal product, hybrid drug, FDA-approved drug.
Current Organic Chemistry
Title:Anti-Cancer Drug Design Using Natural and Synthetic Pharmacophores
Volume: 19 Issue: 15
Author(s): Pinaki S. Bhadury and Jun Pang
Affiliation:
Keywords: Anti-cancer drug, phamacophoric scaffold, oncology, synthesis, natural & herbal product, hybrid drug, FDA-approved drug.
Abstract: Despite incredible advancement made in recent years, treatment of cancer still remains the most challenging task for the mankind. The new small molecule therapeutic drugs are more specific, exhibit better therapeutic efficacy and mostly contain scaffolds of β-lactam, sulfonamide, quinoline, quinazoline, quinoxaline, purine, pyrimidine, resorcinol, pyrazole/isoxazole, benzamide etc. The structure-activity relationships of different pharmacophores that have been reported to potently inhibit cell growth of human tumour cell lines are constantly being investigated. Development of products of natural origin can also prove effective without submitting to harmful radiation and chemotherapy treatments. Under these circumstances, the practicing organic chemists are greatly facing the challenge of designing new and leading anti-cancer drugs based on natural products and scaffolds of potent pharmacaophores. The review intends to cover new approach of anti-cancer drug design using natural and synthetic pharmacophores. The plausible synthetic routes to major drugs for oncology that were approved recently by Food and Drug Administration (FDA) are also discussed.
Export Options
About this article
Cite this article as:
S. Bhadury Pinaki and Pang Jun, Anti-Cancer Drug Design Using Natural and Synthetic Pharmacophores, Current Organic Chemistry 2015; 19 (15) . https://dx.doi.org/10.2174/1385272819666150525234749
DOI https://dx.doi.org/10.2174/1385272819666150525234749 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Omega-3 Fatty Acid Treatment Combined with Chemotherapy to Prevent
Toxicity, Drug Resistance, and Metastasis in Cancer
Current Drug Targets Intravesical Drug Delivery into the Bladder to Treat Cancers
Current Drug Delivery Role of Phase II Drug Metabolizing Enzymes in Cancer Chemoprevention
Current Drug Metabolism Addressing the Challenge: Current and Future Directions in Ovarian Cancer Therapy
Current Gene Therapy The Therapeutic Value of Natural Agents to Treat miRNA Targeted Breast Cancer in African-American and Caucasian-American Women
Current Drug Targets Recent Developments on 1,2,4-Triazole Nucleus in Anticancer Compounds: A Review
Anti-Cancer Agents in Medicinal Chemistry Clinical Proteomics in Application to Predictive Diagnostics and Personalized Treatment of Diabetic Patients
Current Proteomics Aquaporin Biology and Nervous System
Current Neuropharmacology The Roles of Chromatin Remodeling Proteins in Cancer
Current Protein & Peptide Science TGR5 as a Therapeutic Target for Treating Obesity
Current Topics in Medicinal Chemistry Editorial (Thematic Issue: Endocrine Related Cancer: From Stem Cells to New Drug Targets)
Current Medicinal Chemistry Editorial ( Thematic Issue: Diabetes and Cancer - Disease, Drugs or Deception?)
Current Drug Safety Purinergic Signalling: What is Missing and Needed Next? The Use of Transgenic Mice, Crystallographic Analysis and MicroRNA
CNS & Neurological Disorders - Drug Targets Toll Like Receptors Signaling Pathways as a Target for Therapeutic Interventions
Current Signal Transduction Therapy The Role of Androgen Receptor Mutations in Prostate Cancer Progression
Current Genomics Organocatalytic Synthesis and Antitumor Activity of Novel 1,2,3-triazoles Derived from Fatty β-ketoesters
Medicinal Chemistry Studies on Anticancer Activities of Lactoferrin and Lactoferricin
Current Protein & Peptide Science Fluorescent Substrates Useful as High Throughput Screening Tools for ADAM9
Combinatorial Chemistry & High Throughput Screening Intracellular Trafficking of MDR Transporters and Relevance of SNPs
Current Topics in Medicinal Chemistry Proteomics in Computer-Aided Drug Design
Current Computer-Aided Drug Design